Author Correction: Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer

Zheng Han; Xiaohui Wu; Sarah Roelle; Chuheng Chen; William P. Schiemann; Zheng-Rong Lu

doi:10.1038/s41467-017-02302-9

Nature Communications (Jan 2018)

Author Correction: Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer

Zheng Han,
Xiaohui Wu,
Sarah Roelle,
Chuheng Chen,
William P. Schiemann,
Zheng-Rong Lu

Affiliations

Zheng Han: Case Center for Biomolecular Engineering, Department of Biomedical Engineering, Case Western Reserve University
Xiaohui Wu: Case Center for Biomolecular Engineering, Department of Biomedical Engineering, Case Western Reserve University
Sarah Roelle: Case Center for Biomolecular Engineering, Department of Biomedical Engineering, Case Western Reserve University
Chuheng Chen: Case Center for Biomolecular Engineering, Department of Biomedical Engineering, Case Western Reserve University
William P. Schiemann: Case Comprehensive Cancer Center, Case Western Reserve University
Zheng-Rong Lu: Case Center for Biomolecular Engineering, Department of Biomedical Engineering, Case Western Reserve University

DOI: https://doi.org/10.1038/s41467-017-02302-9
Journal volume & issue: Vol. 9, no. 1
pp. 1 – 1

Abstract

Read online

In the original version of this Article, the penultimate sentence of the Abstract incorrectly read ‘The dose of the contrast agent for effective molecular MRI is only slightly lower than that of ZD2-Cy5.5 (0.5 µmol kg−1) in fluorescence imaging.’ The correct version states ‘higher’ in place of ‘lower’. This error has been corrected in both the PDF and HTML versions of the Article.

Published in Nature Communications

ISSN: 2041-1723 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Science
Website: https://www.nature.com/ncomms/

About the journal